Upstream Bio Alternatives & Competitors
12 companies similar to Upstream Bio — Developing treatments for inflammatory diseases
Companies similar to Upstream Bio
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
Zenas BioPharma
Enabling patients with autoimmune diseases to reimagine life
Waltham, United States
Calluna Pharma
Developing first-in-class therapies designed to defeat chronic inflammation and fibrosis a...
Oslo, Norway
Dianthus Therapeutics, Inc.
Building a leading biotech company focused in severe autoimmune diseases.
United States
Rival Readout
Competing with Upstream Bio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
London, United Kingdom
Orca Bio
Transforming allogeneic cell therapy for patients with cancer and autoimmune diseases.
Menlo Park, United States
Pharvaris
Pioneering science for patient choice
Zug, Switzerland
Orchard Therapeutics - U.S.
Dedicated to transforming the lives of patients with severe and other genetic diseases thr...
London, United Kingdom
Nuvamid
A clinical stage biotech focused on the research and use of nucleotides, as therapeutics f...
Nyon, Switzerland
Third Harmonic Bio
Advancing the next wave of medicine for inflammatory diseases
San Francisco, United Sta...
FimmCyte
First disease modifying treatment for Endometriosis.
Basel, Switzerland
Azome Therapeutics
Developing selective NLRP3 inflammasome inhibitors for severe inflammatory diseases
About Upstream Bio
Upstream Bio, founded in 2021, is a promising player in the Biotechnology sector with a focus on Health Care and Pharmaceuticals, headquartered in the United States. The company's slogan, "Developing treatments for inflammatory diseases," underscores its mission in the health and wellness arena. Central to their innova...
Development of verekitug for targeting TSLP in inflammatory diseases, Conducting clinical trials for respiratory disease treatments, Research and innovation in chronic inflammatory diseases
Patients with chronic respiratory diseases, Healthcare professionals specializing in respiratory health, Researchers and clinicians in the field of inflammatory diseases
Inflammatory Diseases, Monoclonal Antibody, Clinical-stage Therapy, VereKitug, Immunotherapy, TSLP Receptor Inhibition, Severe Asthma, Immune Cell Signaling, Pharmaceutical Development, Upstream Immune Modulation, Chronic Disease Treatment
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Upstream Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Upstream Bio on 9 Jun 2026. The 12 companies listed here were last checked between 7 Jun 2025 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
